Diminution of early insulin response to glucose subjects with normal but minimally elevated fasting plasma glucose. Evidence for early β-cell dysfunction

Diabetic Medicine

Volumn 19, Issue 7, 2002, Pages 566-571

  Sato, Y ^a   Komatsu, M ^a   Katakura, M ^b   Ohfusa, H ^c   Yamada, S ^a   Yamauchi, K ^a   Hiramatsu, K ^a   Ichikawa, K ^a   Aizawa, T ^a   Hashizume, K ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Koshoku Central Hospital   (Japan)

^c NAGANO RED CROSS HOSPITAL   (Japan)

Author keywords

cell dysfunction; Japanese; Oral glucose tolerance test

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; B LYMPHOCYTE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; HEALTH CARE PERSONNEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESPONSE; JAPAN; LYMPHOCYTE FUNCTION; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; JAPAN; MALE; MIDDLE AGED;

EID: 0036417160     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2002.00746.x     Document Type: Article

References (40)

1. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Charles MA, Bennett PH. A two step model for development of non-insulin-dependent diabetes. Am J Med 1991; 90: 229-235.
2. DeFronzo RA, Bonadonna BC, Ferrannini E. Pathogenesis of NIDDM. In Alberti KGGM, Zimmet P, DeFronzo RA eds. International Textbook of Diabetes Mellitus, 2nd Edn. Chichester: John Wiley & Sons, 1997: 635-711.
3. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999; 104: 787-794.
4. Yoneda H, Ikegami H, Yamamoto Y, Yamato E, Cha T, Kawaguchi Y et al. Analysis of early phase insulin response in non-obese subjects with mild glucose intolerance. Diabetes Care 1992; 15: 1517-1521.
5. Cerasi E, Lufut R, Efendic S. Decreased sensitivity of the pancreatic beta cells to glucose in prediabetic and diabetic subjects. A glucose dose-response study. Diabetes 1972; 21: 224-234.
6. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin Cet al. Early metabolic defects in persons at increased risk for non-insulin dependent diabetes mellitus. N Engl J Med 1996; 321: 337-343.
7. Yoshinaga H, Kosaka K. Heterogeneous relationship of early insulin response and fasting insulin level with development of non-insulin-dependent diabetes mellitus in non-diabetic Japanese subjects with or without obesity. Diabetes Res Clin Pract 1999; 44: 129-136.
8. Matsumoto K, Miyake S, Yano M, Ueki Y, Yamaguchi Y, Akazawa S et al. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects. Diabetes Care 1997; 20: 1563-1568.
9. Kadowaki T, Miyake Y, Hagura R, Akanuma Y, Kajinuma H, Kuzuya N et al. Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia 1984; 26: 44-49.
10. The expert committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1197.
11. Alberti KG, Zimmet PZ. Definition, diagnosis, and classification of diabetes mellitus and its complications. Diabet Med 1998; 15: 539-553.
12. Kosaka K, Hagura R, Kuzuya T, Kuzuya N. Insulin secretory response of diabetes during the period of improvement of glucose tolerance to normal range. Diabetologia 1974; 10: 775-782.
13. Kosaka K, Kuzuya T, Hagura R, Yoshinaga H. Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: The usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes. Diabet Med 1996; 13: S109-S119.
14. Hermans MP, Levy JC, Morris RJ, Turner RC. Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia 1999; 42: 678-687.
15. Olefsky JM, Farquhar JW, Reaven G. Relationship between fasting plasma insulin level and resistance to insulin-mediated glucose uptake in normal and diabetic subjects. Diabetes 1973; 22: 507-513.
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis Model Assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28: 412-419.
17. Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 1979; 74: 829-836.
18. Nauck MA, Sauerwald A, Ritzel R, Holst JJ, Schmiegel W. Influence of glucagon-like peptide 1 on fasting glycaemia in type 2 diabetic subjects treated with insulin after sulfonylurea secondary failure. Diabetes Care 1998; 21: 1925-1931.
19. Emura M, Nakanome H, Ito A. Immunoreactive proinsulin detected by enzyme-linked immunosorbent assay. Biomed Res 1997; 18: 389-393.
20. Bergman RN. Toward physiological understanding of glucose tolerance: Minimal model approach. Diabetes 1989; 38: 1512-1527.
21. Yoshiike N, Matsumura Y, Zamann MM, Yamaguchi M. Descriptive epidemiology of body mass index in Japanese adults in a representative sample from a National Nutrition Survey, 1990-1994. Int J Obes Relat Metab Disord 1998; 22: 684-687.
22. Isram MM, Horibe H, Kobayashi F. Current trend in prevalence of diabetes mellitus in Japan, 1964-1992. J Epidemiol 1999; 9: 155-162.
23. Brunzell JD, Robertson RP, Lerner RL, Hazzard WR, Ensinck JW, Bierman EL et al. Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab 1976; 42: 222-229.
24. Lillioja S, Mott DM, Howard BV, Bennett PH, Yki-Jarvinen H, Freymond D et al. Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 1998; 318: 1217-1225.
25. Pratley RE, Weyer C, Bogarudus C. Metabolic abnormalities in the development of type 2 diabetes. In LeRoith D, Taylor SI, Olefsky JM, eds. Diabetes Mellitus. A Fundamental and Clinical Text, 2nd Edn. Philadelphia: Lippincott Williams & Wilkins, 2000: 548-557.
26. Haffner SM, Miettinen H, Gaskill SP, Stern MP. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes 1995; 44: 1386-1391.
27. Haffner SM, Miettinen H, Gaskill SP, Stern M. Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance. Diabetologia 1996; 39: 1201-1207.
28. DeFronzo RA, Ferrannini E, Simonson DC. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: Contribution of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 1989; 38: 387-395.
29. Thomas AE, McKay DA, Cutlip MB. A nomogram method for assessing body weight. Am J Clin Nutr 1976; 29: 302-304.
30. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinaemia: The key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416-422.
31. Snehalatha C, Ramachandran A, Satyavani K, Vijay V, Haffner SM. Specific insulin and proinsulin concentrations in nondiabetic South Indians. Metabolism 1998; 47: 230-233.
32. Reaven GM, Chen YDI, Hollenbeck CB, Sheu WHH, Ostrega D, Polonsky KS. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab 1993; 76: 44-48.
33. Martin FIR, Wyatt GB, Griew AR, Haurahelia M, Higginbotham L. Diabetes mellitus in urban and rural communities in Papua New Guinea. Studies of prevalence and plasma insulin. Diabetologia 1980; 18: 369-374.
34. Reaven GM, Hollenbeck CB, Chen YD. Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance. Diabetologia 1989; 32: 52-55.
35. Matthaei SM, Stumvoll M, Kellerer M, Haring H-U. Pathophysiology and pharmacological treatment of insulin resistance. Endocr Rev 2001; 21: 585-618.
36. Davies MJ, Metcalfe J, Gray IP, Day JL, Hales CN. Insulin deficiency rather than hyperinsulinaemia in newly diagnosed type 2 diabetes. Diabet Med 1993; 10: 305-312.
37. Kobayashi T, Nakanishi K, Sugimoto T, Itoh T, Murase T, Kosaka K et al. Maleness as risk factor for slowly progressive IDDM. Diabetes Care 1983; 12: 7-11.
38. Ozanne SE, Hales CN. The long-term consequences of intra-uterine protein malnutrition for glucose metabolism. Proc Nutr Soc 1999; 58: 615-619.
39. Fajans SS, Bell GI. Maturity-onset diabetes of the young. In LeRoith D, Taylor SI, Olefsky JM, eds. Diabetes Mellitus. A Fundamental and Clinical Text, 2nd Edn. Philadelphia: Lippincott Williams & Wilkins, 2000: 691-705.
40. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990; 263: 2893-2898.